Jonathan McNeill - 11 Jul 2023 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Chief Business Officer
Signature
/s/ Richard Scalzo, Attorney-in-Fact
Issuer symbol
DYN
Transactions as of
11 Jul 2023
Net transactions value
$0
Form type
4
Filing time
04 Apr 2024, 21:06:10 UTC
Previous filing
14 Jun 2023
Next filing
13 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DYN Stock option (right to buy) Award $0 +35,000 $0.000000 35,000 11 Jul 2023 Common Stock 35,000 $11.79 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is being reported late due to an inadvertent administrative error.
F2 This option award was granted on July 11, 2023 and vests over four years in equal monthly installments, with the first vesting occurring on August 1, 2023 and the remaining vesting occurring each month subsequent to the first vesting date, subject to continuous service.